JP2006507303A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006507303A5 JP2006507303A5 JP2004550151A JP2004550151A JP2006507303A5 JP 2006507303 A5 JP2006507303 A5 JP 2006507303A5 JP 2004550151 A JP2004550151 A JP 2004550151A JP 2004550151 A JP2004550151 A JP 2004550151A JP 2006507303 A5 JP2006507303 A5 JP 2006507303A5
- Authority
- JP
- Japan
- Prior art keywords
- diabetes
- oxopropanoate
- ethyl
- phenyl
- benzyloxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US42325302P | 2002-11-01 | 2002-11-01 | |
| PCT/US2003/034185 WO2004041165A2 (en) | 2002-11-01 | 2003-10-28 | Compounds for the treatment of metabolic disorders |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2006507303A JP2006507303A (ja) | 2006-03-02 |
| JP2006507303A5 true JP2006507303A5 (enExample) | 2006-09-28 |
Family
ID=32312627
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004550151A Pending JP2006507303A (ja) | 2002-11-01 | 2003-10-28 | 代謝障害の処置のための化合物 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US7645772B2 (enExample) |
| EP (1) | EP1556085A4 (enExample) |
| JP (1) | JP2006507303A (enExample) |
| AU (1) | AU2003286728A1 (enExample) |
| CA (1) | CA2502297C (enExample) |
| WO (1) | WO2004041165A2 (enExample) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2341513C2 (ru) * | 2001-06-12 | 2008-12-20 | Веллстат Терапьютикс Корпорейшн | Соединения для лечения метаболических заболеваний |
| ES2530235T3 (es) * | 2003-02-13 | 2015-02-27 | Wellstat Therapeutics Corporation | Compuestos para el tratamiento de trastornos metabólicos |
| ES2353601T3 (es) | 2003-04-15 | 2011-03-03 | Wellstat Therapeutics Corporation | Compuestos para el tratamiento de trastornos metabólicos. |
| CN1777576A (zh) | 2003-04-22 | 2006-05-24 | 维尔斯达医疗公司 | 用于治疗代谢紊乱的化合物 |
| CA2522738C (en) * | 2003-04-30 | 2011-11-08 | Wellstat Therapeutics Corporation | Compounds for the treatment of metabolic disorders |
| MXPA06001963A (es) * | 2003-08-20 | 2006-05-31 | Wellstat Therapeutics Corp | Compuestos para el tratamiento de trastornos metabolicos. |
| AU2005249410A1 (en) * | 2004-05-14 | 2005-12-15 | Emisphere Technologies, Inc. | Aryl ketone compounds and compositions for delivering active agents |
| WO2006127133A2 (en) * | 2005-04-01 | 2006-11-30 | Wellstat Therapeutics Corporation | Compounds for the treatment of metabolic disorders |
| UA95613C2 (ru) * | 2005-11-09 | 2011-08-25 | Уеллстат Терепьютикс Корпорейшн | Соединения для лечения расстройсв метаболизма |
| EP1976510A4 (en) * | 2006-01-25 | 2010-06-09 | Wellstat Therapeutics Corp | COMPOUNDS FOR THE TREATMENT OF METABOLISM DISORDER |
| US7820721B2 (en) * | 2006-01-25 | 2010-10-26 | Wellstat Therapeutics Corporation | Compounds for the treatment of metabolic disorders |
| AU2007208127A1 (en) * | 2006-01-25 | 2007-08-02 | Wellstat Therapeutics Corporation | Compounds for the treatment of metabolic disorders |
| JP2009525982A (ja) * | 2006-02-02 | 2009-07-16 | ウェルスタット セラピューティクス コーポレイション | 代謝障害の治療のための化合物 |
| EP1983972A4 (en) * | 2006-02-13 | 2012-01-25 | Wellstat Therapeutics Corp | COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS |
| KR20080098615A (ko) * | 2006-02-28 | 2008-11-11 | 웰스태트 테러퓨틱스 코포레이션 | 물질대사 장애의 치료용 화합물 |
| WO2007117791A2 (en) * | 2006-03-31 | 2007-10-18 | Wellstat Therapeutics Corporation | Combination treatment of metabolic disorders |
| CA2651598A1 (en) * | 2006-05-18 | 2007-11-29 | Wellstat Therapeutics Corporation | Compounds for the treatment of metabolic disorders |
| US20100234464A1 (en) * | 2006-06-09 | 2010-09-16 | Wellstat Therapeutics Corporation | Compounds for the treatment of metabolic disorders |
| CA2661293A1 (en) * | 2006-08-17 | 2008-02-21 | Wellstat Therapeutics Corporation | Combination treatment for metabolic disorders |
| WO2009091732A1 (en) * | 2008-01-15 | 2009-07-23 | Wellstat Therapeutics Corporation | Compounds for the treatment of metabolic disorders |
| US8829058B2 (en) * | 2008-03-13 | 2014-09-09 | Wellstat Therapeutics Corporation | Compounds and method for reducing uric acid |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5225734A (en) | 1975-08-23 | 1977-02-25 | Kyorin Pharmaceut Co Ltd | Process for preparation of 4-(4'-halogenobenzyloxy)-bonzoyl acetate |
| JPS5515460A (en) | 1978-07-20 | 1980-02-02 | Hisamitsu Pharmaceut Co Inc | Novel 2-substituted-benzoylpropionic acid derivative |
| JPS6140270A (ja) | 1984-08-01 | 1986-02-26 | Morishita Seiyaku Kk | ピリダジノン誘導体 |
| FR2752422B1 (fr) * | 1996-08-16 | 1998-11-06 | Lipha | Composition pharmaceutique contenant des acides 4-oxo-butanoiques |
| WO2001081340A2 (en) | 2000-04-24 | 2001-11-01 | Bristol-Myers Squibb Company | Heterocycles that are inhibitors of impdh enzyme |
| AU2001271718A1 (en) | 2000-06-29 | 2002-01-14 | Smith Kline Beecham Corporation | Fatty acid synthase inhibitors |
| US6982348B2 (en) | 2001-01-26 | 2006-01-03 | Takeda Pharmaceutical Company Limited | Aminoethanol derivatives |
| RU2341513C2 (ru) * | 2001-06-12 | 2008-12-20 | Веллстат Терапьютикс Корпорейшн | Соединения для лечения метаболических заболеваний |
| ES2530235T3 (es) * | 2003-02-13 | 2015-02-27 | Wellstat Therapeutics Corporation | Compuestos para el tratamiento de trastornos metabólicos |
| ES2353601T3 (es) * | 2003-04-15 | 2011-03-03 | Wellstat Therapeutics Corporation | Compuestos para el tratamiento de trastornos metabólicos. |
| WO2006127133A2 (en) | 2005-04-01 | 2006-11-30 | Wellstat Therapeutics Corporation | Compounds for the treatment of metabolic disorders |
-
2003
- 2003-10-28 CA CA2502297A patent/CA2502297C/en not_active Expired - Fee Related
- 2003-10-28 JP JP2004550151A patent/JP2006507303A/ja active Pending
- 2003-10-28 US US10/532,690 patent/US7645772B2/en not_active Expired - Fee Related
- 2003-10-28 EP EP03777939A patent/EP1556085A4/en not_active Withdrawn
- 2003-10-28 WO PCT/US2003/034185 patent/WO2004041165A2/en not_active Ceased
- 2003-10-28 AU AU2003286728A patent/AU2003286728A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US7645772B2 (en) | Treatment of metabolic disorders | |
| JP2009531288A (ja) | 代謝障害の処置のための化合物 | |
| JP2009531288A5 (enExample) | ||
| JP2009537559A (ja) | 代謝障害の処置のための化合物 | |
| US20040209891A1 (en) | Treatment of type 2 diabetes with inhibitors of dipeptidyl peptidase IV | |
| KR101934328B1 (ko) | 아모디아퀸 및 항당뇨 약물을 유효성분으로 함유하는 당뇨병의 예방 또는 치료용 약학적 조성물 | |
| AU2007235145B2 (en) | Combination treatment of metabolic disorders | |
| JP2009531280A (ja) | 代謝障害を処置するための化合物 | |
| SK14922002A3 (sk) | Farmaceutický prostriedok na prevenciu, zlepšenie a/alebo liečenie diabetickej komplikácie a použitie postprandiálnej látky na zníženie hladiny krvného cukru | |
| JP4697973B2 (ja) | 代謝障害の処置のための化合物 | |
| JP2006525331A (ja) | 代謝障害の処置のための化合物 | |
| EA015382B1 (ru) | Применение рофлумиласта для лечения сахарного диабета типа 2 | |
| UA80195C2 (en) | Compounds for the treatment of metabolic disorders | |
| JP4703563B2 (ja) | 代謝障害を治療するための化合物 | |
| UA97123C2 (uk) | Застосування індазолметоксиалканової кислоти для зниження рівнів тригліцериду, холестерину та глюкози | |
| JP5252585B2 (ja) | 代謝障害の治療のための化合物 | |
| EP1919472B1 (en) | Compositions and methods for treatment and prevention of hyperuricemia related health consequences | |
| JP2009525982A (ja) | 代謝障害の治療のための化合物 | |
| JP2002173426A (ja) | 血糖低下剤 |